A Medical Device Daily

Neoprobe (Dublin, Ohio), a developer of oncology and cardiovascular surgical and diagnostic products, said that it has entered into a national distribution agreement with Estech (San Ramon, California) for distribution in the U.S. of the Quantix/OR blood flow measurement system.

The Quantix/OR is designed to provide surgeons with quantitative hemodynamic information in coronary artery bypass graft (CABG) and carotid endarterectomy procedures.

“We believe that this agreement is an important step in our continuing effort to provide physicians with innovative new technologies for improving cardiac surgery outcomes,” said Ray Bertolero, Estech vice president and co-founder.

“The Estech agreement provides us with a proven national marketing organization and validates our belief in the blood flow measurement market,” said David Bupp, President of Neoprobe. “By joining a leader in servicing the CABG marketplace, the Quantix/OR system will be better positioned to achieve broader market penetration. The strength of Estech's product offering will allow us to establish a strong presence in the key market for our blood flow products.”